Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 581

1.

A versatile tool for conditional gene expression and knockdown.

Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P.

Nat Methods. 2006 Feb;3(2):109-16.

PMID:
16432520
2.

Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.

Szulc J, Aebischer P.

Methods Mol Biol. 2008;434:291-309. doi: 10.1007/978-1-60327-248-3_18.

PMID:
18470652
3.

A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.

Wu RH, Cheng TL, Lo SR, Hsu HC, Hung CF, Teng CF, Wu MP, Tsai WH, Chang WT.

J Gene Med. 2007 Jul;9(7):620-34.

PMID:
17486668
4.

Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA.

Tang FC, Meng GL, Yang HB, Li CJ, Shi Y, Ding MX, Shang KG, Zhang B, Xue YF.

Stem Cells. 2004;22(1):93-9.

5.

Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo.

Centlivre M, Zhou X, Pouw SM, Weijer K, Kleibeuker W, Das AT, Blom B, Seppen J, Berkhout B, Legrand N.

Gene Ther. 2010 Jan;17(1):14-25. doi: 10.1038/gt.2009.109. Epub 2009 Sep 3.

PMID:
19727135
6.

[*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].

Yao DS, Li L, Garson K, Vanderhyden BC.

Zhonghua Fu Chan Ke Za Zhi. 2006 May;41(5):333-8. Chinese.

PMID:
16762191
7.

Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.

Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN.

J Neurosci Methods. 2007 Jul 30;163(2):338-49. Epub 2007 Mar 3.

PMID:
17397931
8.

Neuron-specific RNA interference using lentiviral vectors.

Nielsen TT, Marion Iv, Hasholt L, Lundberg C.

J Gene Med. 2009 Jul;11(7):559-69. doi: 10.1002/jgm.1333.

PMID:
19434604
9.

Lentiviral vectors: regulated gene expression.

Kafri T, van Praag H, Gage FH, Verma IM.

Mol Ther. 2000 Jun;1(6):516-21.

10.

Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D.

Curr Gene Ther. 2008 Dec;8(6):461-73. Review.

PMID:
19075629
11.
13.

Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo.

Laurenti E, Barde I, Verp S, Offner S, Wilson A, Quenneville S, Wiznerowicz M, Macdonald HR, Trono D, Trumpp A.

Stem Cells. 2010 Aug;28(8):1390-8. doi: 10.1002/stem.460.

14.

Knockdown of human p53 gene expression in 293-T cells by retroviral vector-mediated short hairpin RNA.

Hao DL, Liu CM, Dong WJ, Gong H, Wu XS, Liu DP, Liang CC.

Acta Biochim Biophys Sin (Shanghai). 2005 Nov;37(11):779-83.

15.

GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.

Liu BH, Yang Y, Paton JF, Li F, Boulaire J, Kasparov S, Wang S.

Mol Ther. 2006 Dec;14(6):872-82. Epub 2006 Aug 10.

16.

Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.

Chtarto A, Yang X, Bockstael O, Melas C, Blum D, Lehtonen E, Abeloos L, Jaspar JM, Levivier M, Brotchi J, Velu T, Tenenbaum L.

Exp Neurol. 2007 Mar;204(1):387-99. Epub 2007 Jan 16.

PMID:
17223106
17.

High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.

Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA.

Stem Cells. 2003;21(1):111-7.

18.

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA.

Cancer Gene Ther. 2006 Nov;13(11):1023-32. Epub 2006 Jun 30.

PMID:
16810314
19.

Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.

Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J.

J Gene Med. 2005 Jun;7(6):803-17.

PMID:
15655804
20.

Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.

Stewart HJ, Leroux-Carlucci MA, Sion CJ, Mitrophanous KA, Radcliffe PA.

Gene Ther. 2009 Jun;16(6):805-14. doi: 10.1038/gt.2009.20. Epub 2009 Mar 5.

PMID:
19262613

Supplemental Content

Support Center